Núria Reig
Direttore Tecnico/Scientifico/R&S presso SOM Innovation Biotech SA
Posizioni attive di Núria Reig
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
SOM Innovation Biotech SA
 SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Núria Reig
Precedenti posizioni note di Núria Reig
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| EPFL Plus | Corporate Officer/Principal | - | - |
| Yale University | Corporate Officer/Principal | - | - |
| University of Geneva | Corporate Officer/Principal | - | - |
Formazione di Núria Reig
| University of Barcelona | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svizzera | 3 |
| Spagna | 3 |
| Stati Uniti | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
SOM Innovation Biotech SA
SOM Innovation Biotech SA Pharmaceuticals: MajorHealth Technology SOM Innovation Biotech SA engages in the discovery and development of new indications for known drugs. Its pipeline consists of repositioned compounds for the treatment of amyloidosis, huntington's disease, hyperplasia, glioblastoma, and alzheimer's disease. The company was founded by Raul Insa Boronat and Ignasi Belda Reig on December 30, 2009 and is headquartered in Barcelona, Spain. | Health Technology |
| EPFL Plus |
- Borsa valori
- Insiders
- Núria Reig
- Esperienza
